158 related articles for article (PubMed ID: 32746551)
1. [Ancillary values of fluorescence in situ hybridization with different gene combination in diagnosis of malignant melanoma].
Ren M; Bai QM; Kong YY; Zhou XY; Chang H; Cai X
Zhonghua Bing Li Xue Za Zhi; 2020 Aug; 49(8):827-833. PubMed ID: 32746551
[No Abstract] [Full Text] [Related]
2. Fluorescence in situ hybridisation as an ancillary tool in the diagnosis of acral melanoma: a review of 44 cases.
Su J; Yu W; Liu J; Zheng J; Huang S; Wang Y; Qi S; Ma X; Chen J; Zhang Y
Pathology; 2017 Dec; 49(7):740-749. PubMed ID: 29037804
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes.
Gerami P; Mafee M; Lurtsbarapa T; Guitart J; Haghighat Z; Newman M
Arch Dermatol; 2010 Mar; 146(3):273-8. PubMed ID: 20231497
[TBL] [Abstract][Full Text] [Related]
4. Malignant Melanoma of the Nail Apparatus: A Fluorescence In Situ Hybridization Analysis of 7 Cases.
Romano RC; Shon W; Sukov WR
Int J Surg Pathol; 2016 Sep; 24(6):512-8. PubMed ID: 27185405
[TBL] [Abstract][Full Text] [Related]
5. A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms.
Gerami P; Li G; Pouryazdanparast P; Blondin B; Beilfuss B; Slenk C; Du J; Guitart J; Jewell S; Pestova K
Am J Surg Pathol; 2012 Jun; 36(6):808-17. PubMed ID: 22588064
[TBL] [Abstract][Full Text] [Related]
6. Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization.
Busam KJ; Fang Y; Jhanwar SC; Pulitzer MP; Marr B; Abramson DH
J Cutan Pathol; 2010 Feb; 37(2):196-203. PubMed ID: 20100177
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi.
Gerami P; Beilfuss B; Haghighat Z; Fang Y; Jhanwar S; Busam KJ
J Cutan Pathol; 2011 Apr; 38(4):329-34. PubMed ID: 21323721
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situ hybridisation.
Morey AL; Murali R; McCarthy SW; Mann GJ; Scolyer RA
Pathology; 2009; 41(4):383-7. PubMed ID: 19404853
[TBL] [Abstract][Full Text] [Related]
9. Melanocytic tumors with spitzoid morphology: correlation of clinicopathologic features and FISH analysis.
Kapişkay DÜ; Ülgen ÖA; İnce Ü; Demirkesen C
Turk J Med Sci; 2023 Aug; 53(4):924-933. PubMed ID: 38031947
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence In Situ Hybridization for Melanoma Diagnosis: A Review and a Reappraisal.
Ferrara G; De Vanna AC
Am J Dermatopathol; 2016 Apr; 38(4):253-69. PubMed ID: 26999337
[TBL] [Abstract][Full Text] [Related]
11. Distinguishing epithelioid blue nevus from blue nevus-like cutaneous melanoma metastasis using fluorescence in situ hybridization.
Pouryazdanparast P; Newman M; Mafee M; Haghighat Z; Guitart J; Gerami P
Am J Surg Pathol; 2009 Sep; 33(9):1396-400. PubMed ID: 19606012
[TBL] [Abstract][Full Text] [Related]
12. Four-color fluorescence in-situ hybridization is useful to assist to distinguish early stage acral and cutaneous melanomas from dysplastic junctional or compound nevus.
Lai Y; Wu Y; Liu R; Lu A; Zhou L; Jia L; Diao X; Li Z
Diagn Pathol; 2020 May; 15(1):51. PubMed ID: 32393283
[TBL] [Abstract][Full Text] [Related]
13. Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe.
Gammon B; Beilfuss B; Guitart J; Gerami P
Am J Surg Pathol; 2012 Jan; 36(1):81-8. PubMed ID: 21989344
[TBL] [Abstract][Full Text] [Related]
14. Comparison of melanoma gene expression score with histopathology, fluorescence in situ hybridization, and SNP array for the classification of melanocytic neoplasms.
Reimann JDR; Salim S; Velazquez EF; Wang L; Williams KM; Flejter WL; Brooke L; Sunder S; Busam KJ
Mod Pathol; 2018 Nov; 31(11):1733-1743. PubMed ID: 29955141
[TBL] [Abstract][Full Text] [Related]
15. The correlation of the standard 5 probe FISH assay with melanocytic tumors of uncertain malignant potential.
Muhlbauer A; Momtahen S; Mihm MC; Wang J; Magro CM
Ann Diagn Pathol; 2017 Jun; 28():30-36. PubMed ID: 28648937
[TBL] [Abstract][Full Text] [Related]
16. Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors.
Al-Rohil RN; Curry JL; Torres-Cabala CA; Nagarajan P; Ivan D; Aung PP; Lyons GF; Bassett RL; Prieto VG; Tetzlaff MT
Hum Pathol; 2016 Jul; 53():73-81. PubMed ID: 27004944
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence in situ hybridization as a diagnostic modality in melanocytic neoplasma.
Gerami P; Geraminegad P
G Ital Dermatol Venereol; 2010 Feb; 145(1):29-35. PubMed ID: 20197743
[TBL] [Abstract][Full Text] [Related]
18. The impact of molecular morphology techniques on the expert diagnosis in melanocytic skin neoplasms.
Ferrara G; Misciali C; Brenn T; Cerroni L; Kazakov DW; Perasole A; Russo R; Ricci R; Crisman G; Fanti PA; Passarini B; Patrizi A
Int J Surg Pathol; 2013 Oct; 21(5):483-92. PubMed ID: 23775023
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence in situ hybridization as a tool for microstaging in malignant melanoma.
Newman MD; Lertsburapa T; Mirzabeigi M; Mafee M; Guitart J; Gerami P
Mod Pathol; 2009 Aug; 22(8):989-95. PubMed ID: 19448594
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases.
Vergier B; Prochazkova-Carlotti M; de la Fouchardière A; Cerroni L; Massi D; De Giorgi V; Bailly C; Wesselmann U; Karlseladze A; Avril MF; Jouary T; Merlio JP
Mod Pathol; 2011 May; 24(5):613-23. PubMed ID: 21151100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]